- Category eNews
- DATE 27 Sep 2022
COSA Lung Cancer Group & TOGA
September 2022
Thoracic Oncology Group of Australasia 2022 Annual Scientific Meeting
You can read more about the presentation highlights and Prof Ball’s and Mr Robson’s contribution to thoracic cancers here.
TOGA Clinical trial program
TOGA's SHERLOCK clinical trial, conducted in collaboration with NHMRC CTC at University of Sydney, is open to recruitment. KRAS G12C is one of the more common 'oncogenic driver' mutations where targeted therapies have enabled improved survival for some patients with NSCLC over the last decade. For years KRAS was considered 'undruggable' but the discovery of sotorasib and adequate molecular testing to identify the KRAS G12C mutation significantly expands treatment options for this subset of patients. Read more on TOGA’s clinical research program
TOGA Podcasts
TOGA Lung Cancer Preceptorship
The event is ideal for any trainees or early fellows with an interest in thoracic cancers, as it provides insight into career paths of the preceptors, provides opportunities for networking and developing mentoring relationships, as well as developing a solid understanding of the clinical management of thoracic cancers and how clinical trials research has contributed to the evidence base for what is practised today.
TOGA podcast 5 gives some insight into preceptors' and preceptees' experience of the event. Registrations close on 2 October, or bookmark yourself a reminder to keep an eye out for registrations opening around August next year.
Would you like to learn more about TOGA? Become a member, follow us on Twitter or Instagram or visit our exhibit at the COSA ASM.
COSA and TOGA
Outside of the close affiliation COSA and its members have with TOGA, we have represented COSA in the 2022 Cancer Australia Lung Cancer Screening Implementation Workshops and continue to offer our active support of this ongoing application to Government. We look forward to an updated MSAC response, which may be available for the closing Presidential Session to be delivered by Hon Greg Hunt at the upcoming COSA ASM. In May 2023 we plan on hosting an inaugural early NSCLC management consensus round table meeting, followed by a wider MDT Masterclass. Details to follow.
Dr Megan Sanders, Executive Officer, TOGA
Dr Malinda Itchins, Chair, COSA Lung Cancer Group
Prof Michael Millward, TOGA Representative, COSA Council
Prof Nick Pavlakis, Chair, TOGA Board of Directors
Join Australia's leading oncology community & make an impact
Become a COSA memberTwitter
@COSAoncology
Follow
COSAoncology 12 hours ago
RT @ACSC_PeterMac: Calling all clinicians interested in survivorship care for #cancersurvivors with treatable but not curable cancers. Regi…
Read More >COSAoncology 12 hours ago
COSA's March eNews is in members' inboxes now ... ... or available to COSA members at https://t.co/DCJYUXIxl3 https://t.co/FW6f8nIXMg
Read More >COSAoncology yesterday
COSA is the national oncology community bringing together multidisciplinary health professionals across all cancers to advance care and improve outcomes. More on member benefits here: https://t.co/4Fw9lbNDrf https://t.co/EGBDBenLQp
Read More >COSAoncology 3 days ago
It only takes a few minutes to join COSA – Plus, join before 30 April 2024 and not only get bonus months of membership, but also save on member rates before prices increase for 2024! Join now: https://t.co/KyH4eMpIOp https://t.co/KuSX6hoRdv
Read More >COSAoncology 6 days ago
Make the most of your COSA membership savings! A discount applies if you’re a member of an Affiliated or Associated organisation. Plus - join before 30 April 2024 to get a saving on member rates before they increase for 2024. https://t.co/szOpiPmIr7 https://t.co/9bcc678y2C
Read More >COSAoncology 7 days ago
2023 was quite a year! COSA members will find the COSA Annual Report 2023 in their inboxes; everyone else can find it at https://t.co/a88OK0m92Z Contains reports from 36 COSA Groups and Affiliate Organisations, as well as overviews from the President, CEO and 2023 ASM Convenor. https://t.co/C1wQQLJQT7
Read More >COSAoncology 8 days ago
RT @LaceyJudith: National Symposium, few places left register now! @COSAoncology @COSA_Surviv @ABigaranAEP @davemiz_EP @DrNicolasHart @drc…
Read More >COSAoncology 9 days ago
RT @M_Jefford: Our correspondence, #OpenAccess in @JCO_ASCO today 🚨 shared care for #cancersurvivors is preferred by pts, cheaper for the h…
Read More >COSAoncology 9 days ago
RT @cancer_K2A: Another big day of great presentations at #WICC2024 If you’re interested in learning how #survonc & supportive care can im…
Read More >COSAoncology 9 days ago
Join or renew your COSA membership before 30 April 2024 to get bonus months of membership and a saving! https://t.co/KyH4eMpIOp https://t.co/8fIetrPa2t
Read More >